引用次数
引用: 1,279
H-指数: 19
I10-指数 : 21
出版物: 60
Seveso et la dioxine
Massimo Binaghi , Caroline Sugnaux , Matthias Baud
2007
Luminescent lanthanide helicates self-assembled from ditopic ligands bearing phosphonic acid or phosphoester units.
Anne-Sophie Chauvin , Steve Comby , Matthias Baud , Cyntia De Piano
Inorganic Chemistry 48 ( 22) 10687 -10696
27
2009
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity
Françoise Borcard , Matthias Baud , Claudia Bello , Giovanna Dal Bello
Bioorganic & Medicinal Chemistry Letters 20 ( 17) 5353 -5356
5
2010
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
Lars Schlotawa , Karolina Tyka , Matthias Kettwig , Rebecca C Ahrens‐Nicklas
EMBO Molecular Medicine 15 ( 3) e14837 -e14837
5
2023
Restoring impaired functions of mutant tumor suppressor p53 using synthetic modulators
Raniya R Khadiullina , Regina M Mirgayazova , Rimma N Mingaleeva , Vitaliy V Chasov
CELL DEATH DISCOVERY 6 ( 1)
2020
Small molecule modulators of mutant p53 demonstrate selective cytotoxicity toward p53-Y220C cell lines
Raniya R Khadiullina , Regina M Mirgayazova , Rimma N Mingaleeva , Vitaliy V Chasov
CELL DEATH DISCOVERY 6 ( 1)
2020
Selective small molecule stabilisers/activators of p53 (Y220C) mutant
Regina Sayarova , Raniya Nazyrova , Rimma Mingaleeva , Olga Kartseva
CELL DEATH DISCOVERY 5
2019
Expression, purification and biophysical studies of mutant p53
Azzam Hamad , Raniya Khadiullina , Regina Sayarova , Razan Sabouni
Материалы XX Зимней молодежной школы ПИЯФ по биофизике и молекулярной биологии 230 -230
2019
Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency
Lars Schlotawa , Matthias Kettwig , Rebecca Ahrens-Nicklas , Matthias Baud
Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions 138 ( 2)
2023
Reactivation of tumor suppressor p53 by aminobenzothiazole derivatives
Raniya Khadiullina , Damir Davletshin , Elvina Khusainova , Regina Mirgayazova
CELL DEATH DISCOVERY 8 9 -9
2022
2-Sulfonylpyrimidines: Reactivity Adjustable Agents for Cysteine Arylation
Maëva Pichon , Dawid Drelinkiewicz , David Lozano , Ruxandra Moraru
2
2023
Selected Applications of Spirocycles in Medicinal Chemistry
Matthias Baud
Spiro Compounds: Synthesis and Applications 9 -34
2022
Synthesis of new potentially anticancerous agents
Matthias Baud
EPFL ( STUDENT)
2008
Heteroaromatic sulfones as warheads for Targeted Covalent Inhibitors (TCIs)
Ruxandra Moraru , Beatriz Valle-Argosb , Lara Buermann , Annabel Minton
Lead Optimisation of Small Molecule Sulfatase Reactivators for MSD
Niama Ezzaidi , Lars Schlotawa , Matthias Baud
Generating TP53 mutant MCF7 cell line with CRISPR/Cas9: cell model for targeted therapies
Regina Mirgayazova , Rania Khadiullina , Rimma Mingaleeva , Matthias Baud
CELL DEATH DISCOVERY 7 ( SUPPL 1) 9 -9
2021
Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors
Matthias G J Baud , Thomas Leiser , Vanessa Petrucci , Mekala Gunaratnam
Beilstein Journal of Organic Chemistry 9 ( 1) 81 -88
18
2013
Enzymes Functional Probes
Enrique Lin Shiao , Matthias Gerard Jacky Baud , Alessio Ciulli , Kwok-Ho Chan
2017
Abstract B166: Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
Matthew J. Fuchter , Matthias G. J. Baud , Thomas Leiser , Sharon Samlal
Molecular Cancer Therapeutics 10
2011
Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
Matthias G. J. Baud , Thomas Leiser , Patricia Haus , Sharon Samlal
Journal of Medicinal Chemistry 55 ( 4) 1731 -1750
70
2012